HLA-C and breast carcinoma: We further compared non-canonical MHC-bound peptides from the ovarian and breast cancer cohorts to previously identified neoantigens from canonical sequences (37) and to those predicted in the TSNAdb database of predicted neoantigens in TCGA cohorts (48).